跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,531 条关于
“C. Ola Landgren”
全部
17,531
临床试验
9,759
药物
2,152
机构
3,120
资讯
2,500
2年前
FDA Panel Supports MRD as Endpoint for Accelerated Approval in Multiple Myeloma
去年
FDA Committee Greenlights Minimal Residual Disease Endpoint for Accelerated Multiple Myeloma Drug Approvals
去年
FDA's Approval of MRD as End Point Transforms Multiple Myeloma Research and Treatment
9天前
BMS GPRC5D CAR-T Arlo-cel Hits Primary Endpoint in Quadruple-Class Exposed Multiple Myeloma
去年
Sylvester Comprehensive Cancer Center to Present Groundbreaking Research at ASCO 2025 Annual Meeting
去年
Darzalex Shows Promise in Smoldering Myeloma, Awaiting Regulatory Decision
昨天
NCCN Multiple Myeloma Guidelines Add Dedicated MRD Testing Page, Name clonoSEQ and Set 10-6 as Preferred Sensitivity
去年
Advancements in Clostridioides difficile Treatment and Prevention Highlighted in 2024
去年
Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer
去年
FDA Approvals in 2024: NASH Treatment, DMD Therapy, Novel Schizophrenia Drug, and Breast Cancer Advancement
第 1 页,共 250 页
上一页
下一页